Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Quick facts
Marketed products
- andrographolide sulfonate
- andrographolide sulfonate simulation · Immunology; Infectious Disease
Andrographolide sulfonate is a water-soluble derivative of andrographolide that exerts anti-inflammatory and immunomodulatory effects through multiple cellular pathways. - Standard treatment+Xiyanping injection · Infectious Disease / Immunology
Xiyanping injection is a traditional Chinese medicine extract that exerts anti-inflammatory, antiviral, and immunomodulatory effects through multiple pathways.
Phase 3 pipeline
- GP681 Simulant · Attention Deficit Hyperactivity Disorder (ADHD)
GP681 Simulant is a stimulant medication that works by increasing the levels of certain neurotransmitters in the brain.
Phase 2 pipeline
- Aolanti Weipang Tablets
Aolanti Weipang Tablets' mechanism of action is not publicly available. - GP681 · Diabetes
GP681 is a small molecule drug that targets the SGLT2 receptor. - SC10914
Phase 1 pipeline
- [14C] GP681
- Aolanti Weikang tablets
- BR790
- DN1406131
- GP681 Powder for Oral Suspension
- S410914 tablet
- Xiyanping injection plus western therapy
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: